Nature's Sunshine Products (NASDAQ:NATR) Posts Quarterly Earnings Results, Beats Expectations By $0.19 EPS

Key Points

• Nature's Sunshine Products reported a quarterly earnings per share (EPS) of $0.35, significantly exceeding analysts' expectations of $0.16.
• The company updated its FY 2025 guidance and achieved revenue of $114.75 million, surpassing expectations of $113.10 million.
• Major shareholder Fosun Pharmaceutical Shanghai sold over 2.8 million shares in June, while Jane Street Group acquired 13,831 shares, indicating ongoing institutional interest in the stock.

Nature's Sunshine Products (NASDAQ:NATR - Get Free Report) announced its quarterly earnings data on Thursday. The company reported $0.35 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.16 by $0.19, Zacks reports. The firm had revenue of $114.75 million for the quarter, compared to analysts' expectations of $113.10 million. Nature's Sunshine Products had a net margin of 3.06% and a return on equity of 10.19%. Nature's Sunshine Products updated its FY 2025 guidance to EPS.

Nature's Sunshine Products Stock Performance

NATR stock traded up $0.16 during mid-day trading on Wednesday, hitting $15.40. The company had a trading volume of 86,581 shares, compared to its average volume of 59,501. The firm has a market cap of $271.59 million, a PE ratio of 20.81 and a beta of 1.14. The stock's fifty day moving average price is $14.92 and its two-hundred day moving average price is $13.96. Nature's Sunshine Products has a 12 month low of $10.81 and a 12 month high of $18.06.

Insiders Place Their Bets

In other news, major shareholder Fosun Pharmaceutical Shanghai sold 2,854,607 shares of the stock in a transaction on Friday, June 27th. The shares were sold at an average price of $11.46, for a total value of $32,713,796.22. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 4.70% of the company's stock.

Institutional Investors Weigh In On Nature's Sunshine Products

A hedge fund recently bought a new stake in Nature's Sunshine Products stock. Jane Street Group LLC purchased a new position in Nature's Sunshine Products, Inc. (NASDAQ:NATR - Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 13,831 shares of the company's stock, valued at approximately $174,000. Jane Street Group LLC owned 0.08% of Nature's Sunshine Products as of its most recent SEC filing. Hedge funds and other institutional investors own 79.40% of the company's stock.

Analyst Ratings Changes

Several research firms recently commented on NATR. Canaccord Genuity Group boosted their price objective on shares of Nature's Sunshine Products from $21.00 to $22.00 and gave the company a "buy" rating in a research report on Friday, August 1st. DA Davidson reaffirmed a "buy" rating and set a $19.00 price target on shares of Nature's Sunshine Products in a report on Tuesday, June 3rd.

About Nature's Sunshine Products

Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.